LWM
GMAB icon

Liberty Wealth Management’s Genmab GMAB Stock Holding History

Liberty Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,105
Closed -$225K – 209
2023
Q1 		$225K Buy
+6,105
New +$235K 0.05% 203
2021
Q4 		– Sell
-671
Closed -$28K – 537
2021
Q3 		$28K Buy
671
+497
+286% +$22.3K 0.01% 564
2021
Q2 		$7K Buy
174
+161
+1,238% +$6.21K ﹤0.01% 724
2021
Q1 		$0 Hold
13
– – ﹤0.01% 976
2020
Q4 		$0 Sell
13
-127
-91% -$4.75K ﹤0.01% 995
2020
Q3 		$5K Buy
+140
New +$5.06K ﹤0.01% 619

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Liberty Wealth Management's GMAB Position: Q2 2023 in Review

Liberty Wealth Management sold out of Genmab (GMAB) in Q2 2023, closing a stake of 6,105 shares — an estimated $225K sold.

Liberty Wealth Management first reported a position in GMAB in Q3 2020 and held it in 6 quarters. The position peaked at $225K in Q1 2023. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.

  • Liberty Wealth Management reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
  • Liberty Wealth Management sold 6,105 Genmab shares in Q2 2023, an estimated $225K.
  • Liberty Wealth Management first reported a position in Genmab in Q3 2020 and held it in 6 quarters.
  • Liberty Wealth Management's Genmab position peaked at $225K in Q1 2023.
  • 213 funds tracked by Wall St. Rank held Genmab as of Q2 2023.

Based on Liberty Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.